Sarada Gurubhagavatula
30 works · 13,543 citations · h-index 13
Top works
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
- Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, ‘Iressa’) on an expanded access study
- Familial Alzheimer's chromosome 14 mutations
- Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid β protein precursor
- XPD and XRCC1 Genetic Polymorphisms Are Prognostic Factors in Advanced Non—Small-Cell Lung Cancer Patients Treated With Platinum Chemotherapy
- Excision Repair Cross-Complementation Group 1 Polymorphism Predicts Overall Survival in Advanced Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy
- A Phase II Study of Gefitinib in Patients with Advanced Thyroid Cancer
- Glucocorticoid stimulation of ileal Na+ absorptive cell brush border Na+/H+ exchange and association with an increase in message for NHE-3, an epithelial Na+/H+ exchanger isoform.
- A novel presenilin‐1 mutation: Increased β‐amyloid and neurofibrillary changes
- Polymorphisms in ERCC1 and Grade 3 or 4 Toxicity in Non–Small Cell Lung Cancer Patients
- Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib
- Genetic heterogeneity of gene defects responsible for familial Alzheimer disease
- SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
- The Role of Adjuvant Chemotherapy for Non-Small Cell Lung Cancer
- O-243 Clinical benefits in patients with advanced non-small-cell lung cancer treated with gefitinib (“Iressa”, ZD1839) in the compassionate use program
- A phase II study of gefitinib in patients with advanced thyroid cancer
- Genetic anticipation in fifteen three-generation families with inflammatory bowel disease
- MO01.42 Myelopreservation with Trilaciclib Regardless of Risk of Chemotherapy-Induced Febrile Neutropenia and/or Anemia or Red Blood Cell Transfusions
- A Phase II study of GT103 in combination with pembrolizumab in refractory, metastatic non–small cell lung cancer
- Polymorphisms of DNA repair and glutathione s-transferase genes and progression-free survival (PFS) in treated advanced esophageal cancer (EC) patients